Skip to main content
See every side of every news story
Published loading...Updated

Anvisa Approves Cultivation of Medicinal Cannabis for Companies, Research, and Patient Associations.

Summary
The approval comes to meet a requirement from the Supreme Federal Court (STF), which set a deadline of March 31st for resolving the issue.

8 Articles

Lean Right

A new resolution broad administration routes, free pharmaceutical manipulation and authorises the import of plant or extracts for the manufacture of medicinal products in the country.

·Brazil
Read Full Article
Left

Five Brazilian states already have laws that authorise medical cultivation

·São Paulo, Brazil
Read Full Article

The National Sanitary Supervisory Agency (Anvisia) adopted a resolution on this Thursday (28) extending the use of cannabis-based therapies. By default, it is allowed to sell canadiol in manipulating pharmaceuticals and plant cultivation in the country — by legal persons.In this case, production is restricted, compatible with the search for items and according to the companies indicated in Anvisia. Related News:Anvisa discussed in this fourth co…

·Quadra, Brazil
Read Full Article

The National Sanitary Supervisory Agency (Anvisia) approved on this Thursday (28) a resolution extending the use of cannabis-based therapies. By default, it is allowed to sell canadiol in manipulating pharmaceuticals and plant production in the country – by companies – returned for the manufacture of medicinal products and other approved products. From this new organ resolution, marketing of medicinal products used by oral, subcutaneous and derm…

Read Full Article

The Spanish Agency for Medicines and Health Products (Aemps) has already announced, through its National Form, the master formula 'patron' for the standardized preparation of cannabis (TCH, CBD) in oral solution, which includes a key point relative to the specialists responsible for its elaboration. It is that, without giving rise to any kind of doubt, the document specifies that this formula must be defined individually by the specialist pharma…

Read Full Article

The new regulation of the National Sanitary Vigilance Agency (Anvisia) represents an important framework for access to treatment with medicinal cannabis in Brazil. Approved on this Thursday (28), the changes extend the access of patients to medicines based on cannabis and make the market more accessible and nationalised. Manipulation Pharmacy Among the main innovations, the authorisation for the sale of cannabis-derived drugs, such as cannabis, …

·Brazil
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources lean Left, 50% of the sources lean Right
50% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

CartaCapital broke the news in São Paulo, Brazil on Wednesday, January 28, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal